Cala Health Reports New Data Demonstrating Increasing Prevalence of Essential Tremor (ET) and High Rates of Depression and Anxiety in Patients With ET

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today reported data demonstrating the increasing prevalence of essential tremor (ET) from 2010 to 2018; a high rate of depression and anxiety in patients with ET; and the safety and efficacy of Cala Trio when used in a real-world setting to treat ET. The data are being reported today in three abstracts at the Virtual ISPOR Europe 2020 conference. ISPOR is t

Click to view original post